Veronica Torrano

6PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 17, 2026
PGC1α-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progression.

|Jun 16, 2026
Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

|Mar 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity.

Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola

|Apr 23, 2025
Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer.

Ariane Schaub-Clerigué, Ivana Hermanova, Ainara Pintor-Rial

|Oct 10, 2019
PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.

Lorea Valcarcel-Jimenez, Alice Macchia, Eva Crosas-Molist

|Sep 21, 2018
CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets.

Ana R Cortazar, Veronica Torrano, Natalia Martín-Martín

Pageof 1

Frequent Collaborators

3 joint publications

Arkaitz Carracedo

2 joint publications

Roger R Gomis

2 joint publications

Asis Palazon

2 joint publications

Ana M Aransay